| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-13 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-08 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.18 | 0.006 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |